Chitkara College of Pharmacy, Chitkara University, Rajpura, Patiala, Punjab, India.
Acta Pharm. 2012 Mar;62(1):93-104. doi: 10.2478/v10007-012-0002-5.
The objective of the present investigation was to prepare and evaluate ocular inserts of moxifloxacin. An ocular insert was made from an aqueous dispersion of moxifloxacin, sodium alginate, polyvinyl alcohol, and dibutyl phthalate by the film casting method. The ocular insert (5.5 mm diameter) was cross-linked by CaCl2 and was coated with Eudragit S-100, RL-100, RS-100, E-100 or L-100. The in vitro drug drainage/permeation studies were carried out using an all-glass modified Franz diffusion cell. The drug concentration and mucoadhesion time of the ocular insert were found satisfactory. Cross-linking and coating with polymers extended the drainage from inserts. The cross-linked ocular insert coated with Eudragit RL-100 showed maximum drug permeation compared to other formulations.
本研究的目的是制备和评价莫西沙星眼部植入剂。眼部植入剂是通过薄膜铸造法由莫西沙星水性分散体、海藻酸钠、聚乙烯醇和邻苯二甲酸二丁酯制成的。眼部植入剂(直径 5.5 毫米)通过 CaCl2 交联,并涂有 Eudragit S-100、RL-100、RS-100、E-100 或 L-100。采用全玻璃改良 Franz 扩散池进行体外药物引流/渗透研究。眼部植入剂的药物浓度和粘膜黏附时间令人满意。交联和聚合物包衣延长了植入物的引流时间。与其他配方相比,交联的 Eudragit RL-100 包衣眼部植入剂显示出最大的药物渗透。